4-Methoxy-5-(4-methyl-5-(4-(piperazin-1-yl)phenyl)pyridin-3-yl)thiophene-3-carboxamide

ID: ALA4538285

PubChem CID: 155548923

Max Phase: Preclinical

Molecular Formula: C22H24N4O2S

Molecular Weight: 408.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1c(C(N)=O)csc1-c1cncc(-c2ccc(N3CCNCC3)cc2)c1C

Standard InChI:  InChI=1S/C22H24N4O2S/c1-14-17(15-3-5-16(6-4-15)26-9-7-24-8-10-26)11-25-12-18(14)21-20(28-2)19(13-29-21)22(23)27/h3-6,11-13,24H,7-10H2,1-2H3,(H2,23,27)

Standard InChI Key:  JBXIPHYYFNQDOC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    2.8381  -17.4788    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8370  -18.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450  -18.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2588  -18.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2560  -17.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5432  -17.0658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5508  -19.5306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8373  -19.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8367  -20.7631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5449  -21.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2591  -20.7598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2562  -19.9406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5535  -21.9913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8403  -22.4036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8392  -23.2213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5497  -23.6330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2588  -23.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2615  -22.4009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9713  -18.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9632  -17.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7112  -17.3897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2559  -16.7773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8418  -16.0700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0412  -16.2454    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.0691  -16.8578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060  -17.6023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5454  -16.1938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8855  -18.1881    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6641  -18.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 10 13  1  0
  4 19  1  0
  5 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
 22 25  1  0
 25 26  1  0
 25 27  2  0
 21 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4538285

    ---

Associated Targets(Human)

ACVR1 Tchem Activin receptor type-1 (1516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.53Molecular Weight (Monoisotopic): 408.1620AlogP: 3.30#Rotatable Bonds: 5
Polar Surface Area: 80.48Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.66CX Basic pKa: 8.88CX LogP: 2.61CX LogD: 1.12
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -0.76

References

1. Ensan D, Smil D, Zepeda-Velázquez CA, Panagopoulos D, Wong JF, Williams EP, Adamson R, Bullock AN, Kiyota T, Aman A, Roberts OG, Edwards AM, O'Meara JA, Isaac MB, Al-Awar R..  (2020)  Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma.,  63  (9): [PMID:32369358] [10.1021/acs.jmedchem.0c00395]

Source